Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
HKD | Fiscal Year Ending | | Latest |
(in millions) | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | | Jun-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 741 | 712 | 996 | 2,825 | 1,483 | 10,888 | 1,574 | 2,615 | 811 | 740 | | 786 |
% Growth | NA | -3.9% | 39.9% | 183.8% | -47.5% | 634.1% | -85.5% | 66.2% | -69.0% | -8.8% | | |
| | | | | | | | | | | | |
Cost of Revenue | (718) | (447) | (522) | (1,954) | (972) | (8,930) | (1,237) | (2,553) | (1,028) | (1,123) | | (1,308) |
Gross Profit | 23 | 265 | 473 | 871 | 511 | 1,958 | 337 | 62 | (217) | (383) | | (523) |
% Revenue | 3.1% | 37.2% | 47.6% | 30.8% | 34.5% | 18.0% | 21.4% | 2.4% | -26.7% | -51.7% | | -66.5% |
| | | | | | | | | | | | |
Research and Development | (21) | (22) | 0 | (5) | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Selling and Marketing | (27) | (22) | (22) | (29) | (30) | (75) | (117) | (140) | (20) | (20) | | (17) |
General and Admin | (135) | (106) | (173) | (240) | (249) | (450) | (400) | (284) | (328) | (255) | | (255) |
Other Inc / (Exp) | (413) | 90 | 520 | 403 | 649 | 410 | (18) | 410 | 14 | 757 | | 59 |
Total Operating Exp | (597) | (60) | 325 | 128 | 370 | (115) | (535) | (14) | (333) | 482 | | (212) |
| | | | | | | | | | | | |
Operating Income | (574) | 205 | 798 | 999 | 881 | 1,843 | (198) | 48 | (550) | 99 | | (735) |
% Revenue | -77.5% | 28.8% | 80.2% | 35.4% | 59.4% | 16.9% | -12.6% | 1.9% | -67.7% | 13.4% | | -93.5% |
| | | | | | | | | | | | |
Interest Expense | (1) | 2 | 51 | 56 | (33) | (184) | (9) | (61) | 42 | (31) | | (11) |
Pre-tax Income | (575) | 207 | 850 | 1,055 | 849 | 1,659 | (207) | (12) | (508) | 68 | | (746) |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | (27) | (74) | (292) | 26 | 0 | 0 | | 0 |
Provision for Taxes | (8) | (25) | (195) | (162) | (134) | (595) | 52 | (104) | (29) | (13) | | 30 |
Net Income to Company | (583) | 182 | 654 | 894 | 687 | 990 | (447) | (91) | (537) | 55 | | (716) |
% Margin | -78.7% | 25.5% | 65.7% | 31.6% | 46.3% | 9.1% | -28.4% | -3.5% | -66.2% | 7.5% | | -91.1% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | (188) | (25) | (16) | (306) | 229 | (98) | (14) | 47 | | 90 |
Net Income to Stockholders | (583) | 182 | 467 | 869 | 671 | 684 | (217) | (189) | (552) | 102 | | (626) |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 27 | 74 | 292 | (26) | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | (583) | 182 | 467 | 869 | 698 | 758 | 74 | (215) | (552) | 102 | | (626) |
% Margin | -78.7% | 25.5% | 46.9% | 30.8% | 47.0% | 7.0% | 4.7% | -8.2% | -68.0% | 13.8% | | -79.7% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | (3.98) | 0.47 | 0.43 | 0.78 | 0.54 | 0.56 | 0.05 | (0.14) | (0.35) | 0.05 | | (0.35) |
Diluted EPS (Continuing Ops) | (3.98) | 0.47 | 0.43 | 0.78 | 0.54 | 0.56 | 0.05 | (0.14) | (0.35) | 0.05 | | (0.35) |
| | | | | | | | | | | | |
WA Basic Shares Out. | 146.35 | 385.25 | 1,083.41 | 1,115.51 | 1,290.53 | 1,343.17 | 1,530.25 | 1,569.38 | 1,569.38 | 2,160.41 | | 3,097.70 |
WA Diluted Shares Out. | 146.35 | 385.44 | 1,083.46 | 1,115.53 | 1,290.53 | 1,343.17 | 1,530.25 | 1,569.38 | 1,569.38 | 2,160.41 | | 3,097.70 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | (575) | 207 | 850 | 1,055 | 849 | 1,659 | (207) | (12) | (508) | 68 | | (746) |
Addback: Net Interest Expense | 1 | (2) | (51) | (56) | 33 | 184 | 9 | 61 | (42) | 31 | | 11 |
Addback: Other Non Operating Expenses, Total | 4 | 1 | (14) | (11) | (11) | (15) | 16 | 35 | 101 | 40 | | 154 |
Addback: Depreciation & Amortization | 72 | 22 | 10 | 40 | 25 | 67 | 72 | 34 | 12 | 11 | | 2 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 2 | 0 | 1 | 8 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 1 | 11 | 1 | (16) | 6 | 177 | 0 | 0 | 0 | (259) | | (259) |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | (0) | (10) | 6 | (0) | (520) | (296) | (0) | 1 | | 63 |
Addback: Asset Writedown | 435 | 0 | (463) | (123) | (256) | 171 | 607 | (144) | (8) | 21 | | (13) |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | (3) | 0 | 0 | (208) | (389) | (691) | (7) | 0 | 0 | (551) | | 3 |
Adjusted EBITDA | (66) | 241 | 336 | 670 | 264 | 1,559 | (28) | (323) | (445) | (639) | | (784) |
% Margin | -8.9% | 33.8% | 33.8% | 23.7% | 17.8% | 14.3% | -1.8% | -12.3% | -54.9% | -86.3% | | -99.8% |
| | | | | | | | | | | | |
Adjusted EBIT | (138) | 218 | 326 | 630 | 240 | 1,492 | (100) | (356) | (457) | (649) | | (786) |
% Margin | -18.6% | 30.7% | 32.7% | 22.3% | 16.1% | 13.7% | -6.4% | -13.6% | -56.4% | -87.7% | | -100.0% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | (583) | 182 | 654 | 894 | 687 | 990 | (447) | (91) | (537) | 55 | | (716) |
Addback: Unusual Items | 432 | 13 | (459) | (358) | (631) | (336) | 81 | (440) | (8) | (788) | | (205) |
Less: Tax Benefit of Unusual Items (26%) | (112) | (3) | 119 | 93 | 164 | 87 | (21) | 114 | 2 | 205 | | 53 |
Adjusted Net Income | (263) | 191 | 315 | 629 | 220 | 742 | (387) | (416) | (543) | (528) | | (867) |
% Margin | -35.5% | 26.8% | 31.6% | 22.3% | 14.8% | 6.8% | -24.6% | -15.9% | -67.0% | -71.3% | | -110.4% |